Description
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis.
Criteria & Qualifications:
• Must be 18 years or older.
• Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis.
• Cannot join if you have other liver diseases or a history of chronic alcohol use.
Compensation:
Contact us for more information